Today's Veterinary Business

APR 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link: https://todaysveterinarybusiness.epubxp.com/i/955830

Contents of this Issue

Navigation

Page 7 of 67

Veterinarians recommend year-round flea and tick protection but... What do dog owners think? While... 62% of dog owners remembered their veterinarian's exact recommendation 2 of dog owners agree that their pets should have 12 months of flea and tick protection 2 73% 1 Brakke Consulting US Flea Control & Heartworm Markets report; 2015. 2 Lavan et al. Parasites & Vectors. 2017; 10:284. 3 Lavan et al. J Vet Sci Technol. 2017; 8:439. 4 BRAVECTO Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 5 BRAVECTO Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 6 BRAVECTO Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 7 Rohdich N, et al. Parasites & Vectors. 2014;7:83. 8 Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. *BRAVECTOkillsfleasandpreventsfleainfestationsfor12weeks.BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kill ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kill lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks. IMPORTANT SAFETY INFORMATION:BRAVECTOhasnotbeenshowntobeeffectivefor12-weeks'durationinpuppiesorkittenslessthan6monthsofage.BRAVECTO Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia,andflatulence.BRAVECTOisnoteffectiveagainstlonestarticksbeyond8weeksofdosing.BRAVECTO Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTOisnoteffectiveagainstlonestarticksbeyond8weeksofdosing.Fortopicaluseonly.Avoidoralingestion.Usecautionindogswithahistoryofseizures.Seizureshavebeenreportedindogsreceivingfluralaner,evenindogswithoutahistoryofseizures.BRAVECTO Topical Solution for Cats:Themostcommonadversereactionsrecordedinclinicaltrialswerevomiting,itching,diarrhea,hairloss,decreasedappetite,lethargy,andscabs/ulceratedlesions.BRAVECTOisnoteffectiveagainstAmericandogticksbeyond8weeksofdosing.Fortopicaluseonly.Avoidoralingestion.Thesafety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO, even in cats without a history of neurologic abnormalities. Copyright © 2018 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc. All rights reserved. US/BRV/0118/0012 The average dog owner doses their pet with approximately 4.6 monthly flea treatments in a year. 1 Is everyone following the 12-month recommendation? No. The challenge

Articles in this issue

Archives of this issue

view archives of Today's Veterinary Business - APR 2018